[The exchangeable potassium in hyper- thyroidism. Application to the study of amyotrophies and Basedowian myasthenia].
D013956:Antithyroid Agents / Q000627:therapeutic use; D001826:Body Fluids / Q000032:analysis; D001835:Body Weight; D005110:Extracellular Space / Q000032:analysis; D005260:Female; D006111:Graves Disease / Q000188:drug therapy; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000378:metabolism*; D011188:Potassium / Q000032:analysis / Q000378:metabolism*; D011865:Radioisotope Dilution Technique; D012964:Sodium / Q000032:analysis; D013148:Spironolactone / Q000627:therapeutic use; D013960:Thyroid Function Tests; D014867:Water / Q000032:analysis; D014882:Water-Electrolyte Balance
D013956:Antithyroid Agents; D014867:Water; D013148:Spironolactone; D012964:Sodium; D011188:Potassium
Le potassium échangeable dans les hyperthyroïdies. Application à l'étude des amyotrophies et de la myasthénie basedowienne.